US8796353B2ExpiredUtilityPatentIndex 93
Biomedical devices containing internal wetting agents
Assignee: JOHNSON & JOHNSON VISION CAREPriority: Sep 10, 2001Filed: Mar 22, 2013Granted: Aug 5, 2014
Est. expirySep 10, 2021(expired)· nominal 20-yr term from priority
Inventors:MCCABE KEVIN PMOLOCK JR FRANK FHILL GREGORY AALLI AZAAMSTEFFEN ROBERT BVANDERLAAN DOUGLAS GFORD JAMES D
C08F 290/068C08F 283/12C08F 290/06A61L 27/18G02B 1/043A61L 27/52C08F 291/00C08F 283/06G02C 7/022A61L 27/26C08F 265/04C08F 271/00C08F 271/02C08F 251/00A61L 2430/16
93
PatentIndex Score
11
Cited by
173
References
11
Claims
Abstract
This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A biomedical device formed from a reaction mixture comprising a high molecular weight hydrophilic polymer and an effective amount of an hydroxyl-functionalized silicone-containing monomer selected from the group consisting of bis-3-methacryloxy-2-hydroxypropyloxypropyl polydimethylsiloxane, 3-methacryloxy-2-(2-hydroxyethoxy)propyloxy)propylbis(trimethylsiloxy) methylsilane, N,N,N′,N′-tetrakis(3-methacryloxy-2-hydroxypropyl)-α,ω-bis-3-aminopropyl-polydimethylsiloxane, and hydroxyl-functionalized silicone containing monomers of formula:
where n=1-50 and R independently comprise H or a polymerizable unsaturated group, with at least one R comprising a polymerizable group, and at least one R comprising H.
2. The biomedical device of claim 1 wherein the effective amount of said hydroxyl-functionalized silicone-containing monomer is about 5% to about 90%.
3. The biomedical device of claim 1 wherein the device is a silicone hydrogel contact lens.
4. The biomedical device of claim 1 comprising about 1% to about 15% high molecular weight hydrophilic polymer.
5. The biomedical device of claim 2 wherein the effective amount of hydroxyl-functionalized silicone-containing monomer is about 10% to about 80%.
6. The biomedical device of claim 1 wherein the effective amount of said hydroxyl-functionalized silicone-containing monomer is about 20% to about 50%.
7. The biomedical device of claim 1 further comprising about 10% to about 40% additional silicone containing monomer, about 10% to about 50% hydrophilic monomers, and about 3% to about 15% high molecular weight hydrophilic polymer.
8. The biomedical device of claim 7 , wherein the device is a soft contact lens.
9. The biomedical device of claim 1 , wherein the hydroxyl-functionalized silicone-containing monomer has a monomer compatibility index of greater than about 0.5.
10. The biomedical device of claim 1 , wherein the high molecular weight hydrophilic monomer is poly-N-vinylpyrrolidone.
11. A method of preparing a biomedical device comprising mixing a high molecular weight hydrophilic polymer and an effective amount of a hydroxyl-functionalized silicone-containing monomer to form a clear solution, and curing said solution.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.